ArticleFrontiers in neurology2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.
- Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines.CNS drugs · 2026Guideline
- Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjögren's syndrome: a systematic review of individual patient data.Rheumatology international · 2024Pooled it
- Socioeconomic burden of AQP4-antibody seropositive NMOSD: a nationwide registry-based study.Journal of neurology, neurosurgery, and psychiatry · 2025Article
- Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases.Therapeutic advances in neurological disorders · 2025Article
- Clinical features and prognosis of NMOSD patients with positive autoimmune antibodies.Frontiers in neurology · 2025Article
- Pediatric Neuroimaging of Multiple Sclerosis and Neuroinflammatory Diseases.Tomography (Ann Arbor, Mich.) · 2024Review
- Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort.Scientific reports · 2024Observational
- Neuromyelitis optica spectrum disorders relapses and seasonal influence in an equatorial country cohort.Revista de neurologia · 2024Article
- A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren's syndrome and pancytopenia treated with inebilizumab.Frontiers in neurology · 2024Article
- Clinical and epidemiological correlates of treatment change in patients with NMOSD: insights from the CIRCLES cohort.Journal of neurology · 2023Observational
- Predictive role of blood-based indicators in neuromyelitis optica spectrum disorders.Frontiers in neuroscience · 2023Article
- NMOSD-Diagnostic Dilemmas Leading towards Final Diagnosis.Brain sciences · 2022Article
- Calculating and Comparing the Annualized Relapse Rate and Estimating the Confidence Interval in Relapsing Neurological Diseases.Frontiers in neurology · 2022Article
- Risk Factors and Nomogram for Predicting Relapse Risk in Pediatric Neuromyelitis Optica Spectrum Disorders.Frontiers in immunology · 2022Article
- Magnetic resonance imaging in neuromyelitis optica spectrum disorder.Clinical and experimental immunology · 2021Review
- Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina.Multiple sclerosis journal - experimental, translational and clinicalArticle
- Hospital Readmission Rates in Patients With Neuromyelitis Optica Spectrum Disorder.International journal of MS careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
66 authors at 20 institutions in 3 countries.
Elham KhalilidehkordiMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Laura ClarkeMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Simon ArnettMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Wajih BukhariMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Sofia Jimenez SanchezMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Cullen O'GormanMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Jing SunMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Kerri M PrainDivision of Immunology, HSQ Pathology Queensland Central Laboratory, Herston, QLD, Australia.
Mark WoodhallNuffield Department of Clinical Neurosciences, John Radcliffe Infirmary, University of Oxford, Oxford, United Kingdom.
Roger SilvestriniDepartment of Immunopathology, Westmead Hospital, Westmead, NSW, Australia.
Christine S BundellSchool of Pathology and Laboratory Medicine, University of Western Australia, Nedlands, WA, Australia.
David AbernethyDepartment of Neurology, Wellington Hospital, Newtown, United Kingdom.
Sandeep BhutaMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Stefan BlumDepartment of Neurology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
Mike BoggildDepartment of Neurology, Townsville University Hospital, Douglas, QLD, Australia.
Karyn BoundyDepartment of Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia.
Bruce J BrewPeter Duncan Neurosciences Unit, Centre for Applied Medical Research and Department of Neurology, St Vincent's Hospital, University of New South Wales, Darlinghurst, NSW, Australia.
Matthew BrownInstitute of Health Biomedical Innovation, Translational Research Institute, Queensland University of Technology, Woolloongabba, QLD, Australia.
Wallace BrownleeDepartment of Neurology, Auckland City Hospital, Grafton, New Zealand.
Helmut ButzkuevenDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
William M CarrollCentre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, Queen Elizabeth II Medical Centre, University of Western Australia, Nedlands, WA, Australia.
Celia ChenFlinders Medical Centre, Flinders University, Bedford Park, SA, Australia.
Alan CoulthardSchool of Medicine, Royal Brisbane and Women's Hospital, University of Queensland, Herston, QLD, Australia.
Russell C DaleWestmead Clinical School, Westmead Hospital, University of Sydney, Westmead, NSW, Australia.
Chandi DasDepartment of Neurology, Canberra Hospital, Garran, ACT, Australia.
Marzena J Fabis-PedriniCentre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, Queen Elizabeth II Medical Centre, University of Western Australia, Nedlands, WA, Australia.
David FulcherSydney Medical School, Royal Prince Alfred Hospital, University of Sydney, Camperdown, NSW, Australia.
David GillisDivision of Immunology, HSQ Pathology Queensland Central Laboratory, Herston, QLD, Australia.
Simon HawkeSydney Medical School, Royal Prince Alfred Hospital, University of Sydney, Camperdown, NSW, Australia.
Robert HeardWestmead Clinical School, Westmead Hospital, University of Sydney, Westmead, NSW, Australia.
Andrew P D HendersonDepartment of Neurology, Westmead Hospital, Westmead, NSW, Australia.
Saman HeshmatMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Suzanne HodgkinsonSouth Western Sydney Medical School, Liverpool Hospital, University of New South Wales, Liverpool, NSW, Australia.
Trevor J KilpatrickFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
John KingDepartment of Neurology, Royal Melbourne Hospital, Parkville, VIC, Australia.
Chris KneeboneDepartment of Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia.
Andrew J KornbergSchool of Paediatrics, Royal Children's Hospital, University of Melbourne, Parkville, VIC, Australia.
Jeannette Lechner-ScottHunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia.
Ming-Wei LinSydney Medical School, Royal Prince Alfred Hospital, University of Sydney, Camperdown, NSW, Australia.
Christopher LynchSchool of Medicine, University of Auckland, Grafton, New Zealand.
Richard A L MacdonellDepartment of Neurology, Austin Health, Heidelberg, VIC, Australia.
Deborah F MasonDepartment of Neurology, Christchurch Hospital, Christchurch, New Zealand.
Pamela A McCombeCentre for Clinical Research, Royal Brisbane and Women's Hospital, University of Queensland, Herston, QLD, Australia.
Jennifer PereiraSchool of Medicine, University of Auckland, Grafton, New Zealand.
John D PollardDepartment of Neurology, Westmead Hospital, Westmead, NSW, Australia.
Sudarshini RamanathanBrain Autoimmunity Group, Institute for Neuroscience and Muscle Research, The Kids Research Institute at the Children's Hospital, Westmead, NSW, Australia.
Stephen W ReddelBrain and Mind Research Institute, University of Sydney, Camperdown, NSW, Australia.
Cameron ShawSchool of Medicine, Deakin University, Waurn Ponds, VIC, Australia.
Judith SpiesSydney Medical School, Royal Prince Alfred Hospital, University of Sydney, Camperdown, NSW, Australia.
James StankovichMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Ian SuttonDepartment of Neurology, St Vincent's Hospital, Darlinghurst, NSW, Australia.
Steve VucicWestmead Clinical School, Westmead Hospital, University of Sydney, Westmead, NSW, Australia.
Michael WalshDepartment of Neurology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
Richard C WongDivision of Immunology, HSQ Pathology Queensland Central Laboratory, Herston, QLD, Australia.
Eppie M YiuSchool of Paediatrics, Royal Children's Hospital, University of Melbourne, Parkville, VIC, Australia.
Michael H BarnettBrain and Mind Research Institute, University of Sydney, Camperdown, NSW, Australia.
Allan G KermodeCentre for Neuromuscular and Neurological Disorders, Perron Institute for Neurological and Translational Science, Queen Elizabeth II Medical Centre, University of Western Australia, Nedlands, WA, Australia.
Mark P MarriottDepartment of Neurology, Royal Melbourne Hospital, Parkville, VIC, Australia.
John ParrattSydney Medical School, Royal Prince Alfred Hospital, University of Sydney, Camperdown, NSW, Australia.
Mark SleeFlinders Medical Centre, Flinders University, Bedford Park, SA, Australia.
Bruce V TaylorMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Ernest WilloughbyDepartment of Neurology, Auckland City Hospital, Grafton, New Zealand.
Fabienne BrilotBrain Autoimmunity Group, Institute for Neuroscience and Muscle Research, The Kids Research Institute at the Children's Hospital, Westmead, NSW, Australia.
Angela VincentNuffield Department of Clinical Neurosciences, John Radcliffe Infirmary, University of Oxford, Oxford, United Kingdom.
Patrick WatersNuffield Department of Clinical Neurosciences, John Radcliffe Infirmary, University of Oxford, Oxford, United Kingdom.
Simon A BroadleyMenzies Health Institute Queensland, Gold Coast Campus, Griffith University, Southport, QLD, Australia.
Griffith University · AUThe University of Sydney · AUWestmead Hospital · AUQueensland Health · AURoyal Prince Alfred Hospital · AUThe University of Western Australia · AUAuckland City Hospital · NZChildren's Hospital at Westmead · AUJohn Radcliffe Hospital · GBPrincess Alexandra Hospital · AURoyal Adelaide Hospital · AUThe Royal Melbourne Hospital · AUThe University of Melbourne · AUUniversity of Auckland · NZUniversity of Tasmania · AUAustin Health · AUCanberra Hospital · AUChristchurch Hospital · NZDeakin University · AUFlinders Medical Centre · AU
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS) show overlap in their clinical features. We performed an analysis of relapses with the aim of determining differences between the two conditions. Cases of NMOSD and age- and sex-matched MS controls were collected from across Australia and New Zealand. Demographic and clinical information, including relapse histories, were recorded using a standard questionnaire. There were 75 cases of NMOSD and 101 MS controls. There were 328 relapses in the NMOSD cases and 375 in MS controls. Spinal cord and optic neuritis attacks were the most common relapses in both NMOSD and MS. Optic neuritis (
Indexed as
aquaporinepidemiologymultiple sclerosisneuromyelitis opticarelapseseasonality
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.